1299 related articles for article (PubMed ID: 16474417)
1. Downregulation of propranolol-sensitive beta-adrenoceptor signaling after inhibition of nitric oxide synthesis.
Whalen EJ; Bates JN; Johnson AK; Lewis SJ
Br J Pharmacol; 2006 Apr; 147(7):755-64. PubMed ID: 16474417
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide (NO) primarily accounts for endothelium-dependent component of beta-adrenoceptor-activated smooth muscle relaxation of mouse aorta in response to isoprenaline.
Akimoto Y; Horinouchi T; Shibano M; Matsushita M; Yamashita Y; Okamoto T; Yamaki F; Tanaka Y; Koike K
J Smooth Muscle Res; 2002 Oct; 38(4-5):87-99. PubMed ID: 12596888
[TBL] [Abstract][Full Text] [Related]
3. Role of beta2-adrenoceptors (beta-AR), but not beta1-, beta3-AR and endothelial nitric oxide, in beta-AR-mediated relaxation of rat intrapulmonary artery.
Pourageaud F; Leblais V; Bellance N; Marthan R; Muller B
Naunyn Schmiedebergs Arch Pharmacol; 2005 Jul; 372(1):14-23. PubMed ID: 16133491
[TBL] [Abstract][Full Text] [Related]
4. Beta-adrenoceptor dysfunction after inhibition of NO synthesis.
Whalen EJ; Johnson AK; Lewis SJ
Hypertension; 2000 Sep; 36(3):376-82. PubMed ID: 10988268
[TBL] [Abstract][Full Text] [Related]
5. Beta 3-adrenoceptor stimulation induces vasorelaxation mediated essentially by endothelium-derived nitric oxide in rat thoracic aorta.
Trochu JN; Leblais V; Rautureau Y; Bévérelli F; Le Marec H; Berdeaux A; Gauthier C
Br J Pharmacol; 1999 Sep; 128(1):69-76. PubMed ID: 10498836
[TBL] [Abstract][Full Text] [Related]
6. Effects of propranolol and L-NAME on beta-adrenoceptor-mediated relaxation in rat carotid artery.
MacDonald A; McLean M; MacAulay L; Shaw AM
J Auton Pharmacol; 1999 Jun; 19(3):145-9. PubMed ID: 10511470
[TBL] [Abstract][Full Text] [Related]
7. Mediators of contraction-evoked skeletal muscle depressor response in anesthetized rats.
Toney GM; Mifflin SW
J Appl Physiol (1985); 1996 Aug; 81(2):578-85. PubMed ID: 8872621
[TBL] [Abstract][Full Text] [Related]
8. The effect of dehydroepiandrosterone on regional blood flow in prepubertal anaesthetized pigs.
Molinari C; Battaglia A; Grossini E; Mary DA; Vassanelli C; Vacca G
J Physiol; 2004 May; 557(Pt 1):307-19. PubMed ID: 15034120
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of beta- but not alpha 1-mediated adrenergic responses in isolated hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP.
Ebihara Y; Karmazyn M
Cardiovasc Res; 1996 Sep; 32(3):622-9. PubMed ID: 8881523
[TBL] [Abstract][Full Text] [Related]
10. Potential role of nitration and oxidation reactions in the effects of peroxynitrite on the function of beta-adrenoceptor sub-types in the rat.
Lewis SJ; Hoque A; Walton TM; Kooy NW
Eur J Pharmacol; 2005 Aug; 518(2-3):187-94. PubMed ID: 16043170
[TBL] [Abstract][Full Text] [Related]
11. Heterologous desensitization of beta-adrenoceptor signal transduction in vivo.
Travis MD; Whalen EJ; Lewis SJ
Eur J Pharmacol; 1997 Jun; 328(1):R1-3. PubMed ID: 9203576
[TBL] [Abstract][Full Text] [Related]
12. Celiprolol: agonist and antagonist effects at cardiac beta 1- and vascular beta 2-adrenoceptors determined under in vivo conditions in the rat.
Alvarez-Guerra M; Alda O; Garay RP
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun; 355(6):689-98. PubMed ID: 9205952
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide-dependent vasodilatation of rabbit femoral artery by beta(2)-adrenergic stimulation or cyclic AMP elevation in vivo.
Xu B; Li J; Gao L; Ferro A
Br J Pharmacol; 2000 Mar; 129(5):969-74. PubMed ID: 10696097
[TBL] [Abstract][Full Text] [Related]
14. Endothelial beta3-adrenoceptors mediate vasorelaxation of human coronary microarteries through nitric oxide and endothelium-dependent hyperpolarization.
Dessy C; Moniotte S; Ghisdal P; Havaux X; Noirhomme P; Balligand JL
Circulation; 2004 Aug; 110(8):948-54. PubMed ID: 15302798
[TBL] [Abstract][Full Text] [Related]
15. Activation of nitric oxide synthase by beta 2-adrenoceptors in human umbilical vein endothelium in vitro.
Ferro A; Queen LR; Priest RM; Xu B; Ritter JM; Poston L; Ward JP
Br J Pharmacol; 1999 Apr; 126(8):1872-80. PubMed ID: 10372832
[TBL] [Abstract][Full Text] [Related]
16. Alpha-vascular responses after short-term and long-term inhibition of nitric oxide synthesis.
Aleixandre A; López-Miranda V; Ortega A
J Cardiovasc Pharmacol; 2001 Feb; 37(2):133-42. PubMed ID: 11209996
[TBL] [Abstract][Full Text] [Related]
17. Noradrenaline, beta-adrenoceptor mediated vasorelaxation and nitric oxide in large and small pulmonary arteries of the rat.
Priest RM; Hucks D; Ward JP
Br J Pharmacol; 1997 Dec; 122(7):1375-84. PubMed ID: 9421285
[TBL] [Abstract][Full Text] [Related]
18. Regional heterogeneity in the haemodynamic responses to urotensin II infusion in relation to UT receptor localisation.
Gardiner SM; March JE; Kemp PA; Maguire JJ; Kuc RE; Davenport AP; Bennett T
Br J Pharmacol; 2006 Mar; 147(6):612-21. PubMed ID: 16314853
[TBL] [Abstract][Full Text] [Related]
19. Changes in cardiovascular responsiveness to dopexamine and beta 1- and beta 2-adrenoceptor function after the chronic treatment of beta-adrenoceptor antagonists and agonists in anaesthetized dogs.
Chang DH; Einstein R
J Auton Pharmacol; 1996 Oct; 16(5):269-79. PubMed ID: 9023671
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide-dependent beta2-adrenergic dilatation of rat aorta is mediated through activation of both protein kinase A and Akt.
Ferro A; Coash M; Yamamoto T; Rob J; Ji Y; Queen L
Br J Pharmacol; 2004 Oct; 143(3):397-403. PubMed ID: 15351777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
